Showing results (1-10 of 104) with videos related to
Sort By:
Pageof 11
Current Neurology and Neuroscience Reports|June 18, 2010
Multiple sclerosis and vitamin D: a review and recommendationsAndrew J Solomon, Ruth H WhithamNeurology. Clinical Practice|April 23, 2016
Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patientsDennis N Bourdette, Daniel M Hartung, Ruth H WhithamNeurology|April 26, 2015
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?Daniel M Hartung, Dennis N Bourdette, Sharia M Ahmed, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
Synthetic Peptide dendrimers block the development and expression of experimental allergic encephalomyelitisKeith W Wegmann, Cynthia R Wagner, Ruth H Whitham, et al.Continuum (Minneapolis, Minn.)|June 5, 2019
Diagnosis, Differential Diagnosis, and Misdiagnosis of Multiple SclerosisAndrew J SolomonJournal of Neuroimmunology|July 7, 2014
Eluding anaphylaxis allows peptide-specific prevention of the relapsing stage of experimental autoimmune encephalomyelitisKeith W Wegmann, H G Archie Bouwer, Ruth H Whitham, et al.Multiple Sclerosis and Related Disorders|December 11, 2019
Two cases of meningitis associated with ocrelizumab therapyMichael Theriault, Andrew J SolomonContinuum (Minneapolis, Minn.)|August 7, 2013
Disclosing a misdiagnosis of multiple sclerosis: do no harm?Andrew J Solomon, Eran KleinNeurologic Clinics|November 18, 2023
Multiple Sclerosis Diagnostic Delay and MisdiagnosisMarwa Kaisey, Andrew J SolomonJournal of Neuroimmunology|April 25, 2013
Targeting T cells responsive to the priming epitope prevent the relapsing phase of experimental autoimmune encephalomyelitisKeith W Wegmann, H G Archie Bouwer, Cynthia R Gregory, et al.Pageof 11